Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

1 Mistake Cannabis Investors Don't Want to Be Making Right Now
1 Mistake Cannabis Investors Don't Want to Be Making Right Now

Federal marijuana legalization is getting more attention in the U.S., and it's now more about when, not if, the change will come to pass. Senate Majority Leader Chuck Schumer released a draft bill

Is Globus Medical's Robotic Surgery Business a Winner?Photo, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Is Globus Medical's Robotic Surgery Business a Winner?

Medical device maker Globus Medical (NYSE: GMED) has been around since 2003, but has only been selling its Excelcius GPS surgery robots since 2017. Its legacy business is well established, but many

2 Supercharged Growth Stocks to Buy Right Now
2 Supercharged Growth Stocks to Buy Right Now

The world is undeniably becoming more digital. And as things like advertising, commerce, and payments move to digital channels, investors have an opportunity to buy into these wealth-creating

Weber's IPO Is Next Week. Here's What Investors Need to Know.
Weber's IPO Is Next Week. Here's What Investors Need to Know.

Just in time for summer grilling season, Weber (NYSE: WEBR) is setting the stage for its initial public offering (IPO). In an updated regulatory filing with the Securities and Exchange Commission

What Does the Market See in Wells Fargo That It Doesn't See in Citigroup?
What Does the Market See in Wells Fargo That It Doesn't See in Citigroup?

If you look at this year's biggest gains in the financial industry, Wells Fargo (NYSE: WFC) is near the top of the list, with its stock climbing roughly 50% year to date. Citigroup (NYSE: C)

Should You Buy Activision Blizzard Stock Ahead of Q2 Earnings?
Should You Buy Activision Blizzard Stock Ahead of Q2 Earnings?

Activision Blizzard (NASDAQ: ATVI) is scheduled to report second-quarter earnings on Tuesday, Aug. 3, after the market closes. After soaring in 2020, the company's shares have barely budged year to

What Does Moderna's Addition to the S&P 500 Mean for Investors?
What Does Moderna's Addition to the S&P 500 Mean for Investors?

Moderna (NASDAQ: MRNA) was recently added to the S&P 500 index. This was a big milestone for the vaccine maker after its breakout year in 2020. In this Motley Fool Live video, recorded on July 19

Social Security Isn't Running Out of Money, but Here's Why I'm Pretending It Is
Social Security Isn't Running Out of Money, but Here's Why I'm Pretending It Is

There are many rumors out there about Social Security, and perhaps the most prominent one is that the program is on the verge of running out of money. In other words, so long future benefits, right?

Why Investors Should Think Twice Before Investing in ContextLogic -- or Wish
Why Investors Should Think Twice Before Investing in ContextLogic -- or Wish

Maybe it is because ContextLogic (NASDAQ: WISH) is a global e-commerce company. Maybe it's because it's a newly public. Or maybe it's gotten caught up in the Reddit crowd. For whatever reason, a lot

Is This Mid-Cap Biotech Stock a Buy Now?Photo, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
Is This Mid-Cap Biotech Stock a Buy Now?

Kodiak Sciences (NASDAQ: KOD) is a mid-cap biotech business building a drug portfolio focused on retina therapeutics. The Palo Alto, California based company has an approximate market cap of $4.5

After Naming a New CFO, Is This Genetic Diagnostics Company a Buy?
After Naming a New CFO, Is This Genetic Diagnostics Company a Buy?

Marc Stapley, CEO of the genomic diagnostics company Veracyte (NASDAQ: VCYT), is enthusiastic about Rebecca Chambers, the new Chief Financial Officer (CFO), who started her role on July 19.

Stapley

Better Buy: AT&T vs. VerizonPhoto, wide shot, wide-angle lens,  Mobile phone network, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/828b91fb-678a-4621-906b-21e972059e7d.png
Better Buy: AT&T vs. Verizon

The competition between AT&T (NYSE: T) and Verizon Communications (NYSE: VZ) has favored Verizon in recent years, as AT&T invested heavily in non-5G assets. Although AT&T made costly mistakes in its

Can Teladoc Health Stock Start Climbing Again?
Can Teladoc Health Stock Start Climbing Again?

Shares of Teladoc Health (NYSE: TDOC) initially fell after a second-quarter earnings report that looked pretty good on its surface. Total revenue more than doubled year over year, allowing the

Is Moderna a Buy?: https://investors.biontech.de/media-materials
Is Moderna a Buy?

In response to the COVID-19 pandemic, many pharmaceutical companies around the world have raced to produce an effective vaccine. Pfizer and its German partner BioNTech were the first to receive

Enel Americas SA (ENIA) Q2 2021 Earnings Call Transcript
Enel Americas SA (ENIA) Q2 2021 Earnings Call Transcript

Image source: The Motley Fool.

Enel Americas SA (NYSE: ENIA)Q2 2021 Earnings CallJul 28, 2021, 12:00 p.m. ET

Operator

Continue reading

Source Fool.com

3 Dividend Stocks Safe Enough to Bet the Farm On
3 Dividend Stocks Safe Enough to Bet the Farm On

Finding a safe dividend stock to buy for the long term is challenging for two reasons. First, companies can only pay dividends if they have ample cash flow. And second, established competitors with

Why Prologis Is Firing on All Cylinders
Why Prologis Is Firing on All Cylinders

One of the biggest themes of the past year and a half has been shortages. The COVID-19 pandemic depleted corporate inventories, and now companies are struggling to fill increasing demand. This

2 Big Changes Happening at HBO Max
2 Big Changes Happening at HBO Max

AT&T (NYSE: T) added 3.6 million HBO Max subscribers in the second quarter, ending the period with 67.5 million. It's already surpassed the lower end of the full-year subscriber guidance management

3 Secrets to Becoming a Stock Market Multimillionaire
3 Secrets to Becoming a Stock Market Multimillionaire

Nearly every investor has a goal of earning as much money as possible in the stock market, but not everyone will be able to achieve that goal. Getting rich by investing is challenging, and you'll

This Under-the-Radar Dementia Treatment Could Reward InvestorsPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
This Under-the-Radar Dementia Treatment Could Reward Investors

After tripling in 2020, neuroscience-focused biotech BioXcel Therapeutics (NASDAQ: BTAI) has stumbled so far in 2021, losing almost half of its value. While the fall may partially be due to a

In a Blizzard of Data, This Company Could Be a Winner for InvestorsPhoto, wide shot, wide-angle lens,  Consumer electronics manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/0defe5ca-333a-451e-9549-4f262e278fc7.png
In a Blizzard of Data, This Company Could Be a Winner for Investors

As the world becomes increasingly digital, companies are collecting and storing more and more data. Cloud-based data platform company Snowflake (NYSE: SNOW) went public in September 2020 to much

Is Novavax a Buy?Photo, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Is Novavax a Buy?

In the race to develop COVID-19 vaccines, Novavax (NASDAQ: NVAX) seems to have gotten the most important part right. The latest clinical trial data for the NVX-CoV2373 vaccine showed 90% overall

American Express Blows Past Earnings Estimates, and There's More to Come
American Express Blows Past Earnings Estimates, and There's More to Come

The light is finally shining at the end of dark tunnel of the pandemic for American Express (NYSE: AXP). The premium credit card company took a wallop while its customers took a break from their

Got $1,500? 3 No-Brainer Stocks to Buy Right Now
Got $1,500? 3 No-Brainer Stocks to Buy Right Now

The U.S. equities market has been on a roller-coaster ride over the last month. Strong bullish sentiment surrounding the reopening economy turned sour due to higher-than-expected inflation in June

2 Reasons to Invest in Crypto -- and 4 Reasons Not to:
2 Reasons to Invest in Crypto -- and 4 Reasons Not to

Got crypto fever? Monday's big surge in the value of Bitcoin (CRYPTO: BTC) and other cryptocurrencies certainly may have stoked your interest.

Before you take the plunge, however, be sure you're